A carregar...
New all oral therapy for chronic hepatitis C virus (HCV): a novel long-term cost comparison
BACKGROUND: In the US, the prevalence of hepatitis C virus (HCV) has surpassed the prevalence of human immunodeficiency virus (HIV), with about 3.3 million people chronically infected with the disease. Given the aging of the Baby Boomer generation and the subsequent implementation of age-based scree...
Na minha lista:
| Publicado no: | Cost Eff Resour Alloc |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4595188/ https://ncbi.nlm.nih.gov/pubmed/26445564 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12962-015-0043-y |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|